Document is current

Do Orally Administered Immunoglobulin-Based Agents Represent the Future of IBD Therapeutics?

Crossref DOI link: https://doi.org/10.1007/s10620-015-3802-x

Published Online: 2015-07-17

Published Print: 2015-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy